FDA lifts hold on trials of gene therapies for sickle cell disease, beta-thalassemia,

The FDA lifted the clinical holds on four studies designed to evaluate two gene therapies for hematologic conditions. The decision allows for …, The FDA lifted the clinical holds on four studies designed to evaluate two gene therapies for hematologic conditions. The decision allows for …, Read More

Scroll to Top